Exact Mass: 473.0828

Exact Mass Matches: 473.0828

Found 82 metabolites which its exact mass value is equals to given mass value 473.0828, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

CMP-N-trimethyl-2-aminoethylphosphonate

[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][2-(trimethylazaniumyl)ethyl]phosphinic acid

C14H27N4O10P2+ (473.1202)


This compound belongs to the family of Pyrimidine Ribonucleoside Diphosphates. These are pyrimidine ribobucleotides with diphosphate group linked to the ribose moiety.

   

Sporidesmin

Hydroxysporidesmin B

C18H20ClN3O6S2 (473.0482)


D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

   

1-(s-glutathionyl)-2,4-dinitrobenzene

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(2,4-dinitrophenyl)sulfanyl]ethyl]carbamoyl}butanoic acid

C16H19N5O10S (473.0853)


1-(s-glutathionyl)-2,4-dinitrobenzene, also known as Dinitrophenyl-S-glutathione or GS-DNP, is classified as a member of the Oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. 1-(s-glutathionyl)-2,4-dinitrobenzene is considered to be practically insoluble (in water) and acidic

   

(2,5-Dihydroxypyrrol-1-yl) 3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carboxylate

2,5-dihydroxy-1H-pyrrol-1-yl 3,6-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9-xanthene]-6-carboxylate

C25H15NO9 (473.0747)


   

(2,5-Dihydroxypyrrol-1-yl) 3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-4-carboxylate

2,5-dihydroxy-1H-pyrrol-1-yl 3,6-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9-xanthene]-4-carboxylate

C25H15NO9 (473.0747)


   

6-Carboxyfluorescein N-succinimidyl ester

1-[[(3,6-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9-[9H]xanthen]-6-yl)carbonyl]oxy]-2,5-pyrrolidinedione

C25H15NO9 (473.0747)


   

Lixivaptan

N-(3-chloro-4-{3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),4,6,11,13-pentaene-9-carbonyl}phenyl)-5-fluoro-2-methylbenzamide

C27H21ClFN3O2 (473.1306)


C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist

   

Monepantel

N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-[(trifluoromethyl)sulphanyl]benzamide

C20H13F6N3O2S (473.0633)


   

S-DNP-Glutathione

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2,4-dinitrophenyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C16H19N5O10S (473.0853)


   

2-Amino-5-[[(2S)-1-[N-(carboxymethyl)-2,3-dinitroanilino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid

2-Amino-4-({1-[(carboxymethyl)(2,3-dinitrophenyl)carbamoyl]-2-sulphanylethyl}-C-hydroxycarbonimidoyl)butanoic acid

C16H19N5O10S (473.0853)


   

2-Amino-5-[[(2S)-1-[N-(carboxymethyl)-2,4-dinitroanilino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid

2-Amino-4-({1-[(carboxymethyl)(2,4-dinitrophenyl)carbamoyl]-2-sulphanylethyl}-C-hydroxycarbonimidoyl)butanoic acid

C16H19N5O10S (473.0853)


   

Sporidesmin

6-chloro-2,3-dihydroxy-7,8-dimethoxy-10,14,18-trimethyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

C18H20ClN3O6S2 (473.0482)


   

Nav1.7 blocker 24

2-[3-(2,6-Dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]-N-{[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl}ethanimidate

C20H16Cl2F3N3O3 (473.0521)


   
   
   
   
   
   

ON-01910

Rigosertib sodium

C21H24NNaO8S (473.112)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents

   

NAN-190 hydrobromide

2-(4-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)BUTYL)ISOINDOLINE-1,3-DIONE HYDROBROMIDE

C23H28BrN3O3 (473.1314)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists NAN-190 hydrobromide is a serotonin receptor 5-HT antagonist. NAN-190 is a selective antagonist of 5-HT1A[1][3].

   
   
   
   

(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride

(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride

C20H19ClF7NO2 (473.0992)


   

5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-carbaldehyde

5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-carbaldehyde

C26H17ClFN3O3 (473.0942)


   
   

9-(1,1-bipheny)-4-yl-3-(4-broMophenyl)carbazole

9-(1,1-bipheny)-4-yl-3-(4-broMophenyl)carbazole

C30H20BrN (473.0779)


   

Rosiglitazone maleate

Rosiglitazone maleate

C22H23N3O7S (473.1257)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents Rosiglitazone maleate (BRL 49653C) is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone maleate is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).

   

(S)-1-(Diphenylphosphino)-2-[(S)-4-isopropyloxazolin-2-yl]ferrocene

(S)-1-(Diphenylphosphino)-2-[(S)-4-isopropyloxazolin-2-yl]ferrocene

C28H20FeNOP (473.0632)


   
   

2-[N-(2-acetyloxyethyl)-2-chloro-4-[(2-cyano-3-nitrophenyl)diazenyl]anilino]ethyl acetate

2-[N-(2-acetyloxyethyl)-2-chloro-4-[(2-cyano-3-nitrophenyl)diazenyl]anilino]ethyl acetate

C21H20ClN5O6 (473.1102)


   

[[[[[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol- 3-yl]acetyl]oxy]acetyl]oxy]acetic acid

[[[[[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol- 3-yl]acetyl]oxy]acetyl]oxy]acetic acid

C23H20ClNO8 (473.0877)


   

Neratinib Impurity 09

Neratinib Impurity 09

C25H20ClN5O3 (473.1255)


   

3-Bromo-9-(1,1:3,1-terphenyl-3-yl)-9H-carbazole

3-Bromo-9-(1,1:3,1-terphenyl-3-yl)-9H-carbazole

C30H20BrN (473.0779)


   
   

3-Bromo-9-(1,1:4,1-terphenyl-4-yl)-9H-carbazole

3-Bromo-9-(1,1:4,1-terphenyl-4-yl)-9H-carbazole

C30H20BrN (473.0779)


   

(2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride

(2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride

C20H19ClF7NO2 (473.0992)


   

(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride

(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride

C20H19ClF7NO2 (473.0992)


   
   
   

4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate

4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate

C15H24ClN3O8S2 (473.0693)


   

N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-[(trifluoromethyl)thio]benzamide

N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-[(trifluoromethyl)thio]benzamide

C20H13F6N3O2S (473.0633)


   

Monepantel

Monepantel

C20H13F6N3O2S (473.0633)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent Monepantel is organic anthelmintic, and acts as a positive allosteric modulator of a nematode-specific clade of nicotinic acetylcholine receptor (nAChR) subunits.

   

4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide

4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide

C20H16Cl2F3N3O3 (473.0521)


Fluxametamide is an insecticide with wide spectrum, acts as an antagonist of GABA- and glutamate-gated chloride channels, with IC50 of 1.95 nM and 225 nM for M. domestica GABACls and GluCls.

   

2-Chloro-5-(3-chloro-phenyl)-6-[(4-cyano-phenyl)-(3-methyl-3H-imidazol-4-YL)-methoxymethyl]-nicotinonitrile

2-Chloro-5-(3-chloro-phenyl)-6-[(4-cyano-phenyl)-(3-methyl-3H-imidazol-4-YL)-methoxymethyl]-nicotinonitrile

C25H17Cl2N5O (473.081)


   

N-{3-[5-(6-Amino-purin-9-YL)-3,4-dihydroxy-tetrahydro-furan-2-YL]-allyl}-2,3-dihydroxy-5-nitro-benzamide

N-{3-[5-(6-Amino-purin-9-YL)-3,4-dihydroxy-tetrahydro-furan-2-YL]-allyl}-2,3-dihydroxy-5-nitro-benzamide

C19H19N7O8 (473.1295)


   

Lixivaptan

Lixivaptan

C27H21ClFN3O2 (473.1306)


C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist

   

Ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate

Ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate

C19H15ClF3N3O4S (473.0424)


   

CDP-N-dimethylethanolamine

CDP-N-dimethylethanolamine

C13H23N4O11P2- (473.0839)


   

Glutamyl-beta-ketophosphonate-adenosine

Glutamyl-beta-ketophosphonate-adenosine

C16H22N6O9P- (473.1186)


   

5-O-[N-(L-glutamyl)-sulfamoyl] adenosine

5-O-[N-(L-glutamyl)-sulfamoyl] adenosine

C15H19N7O9S-2 (473.0965)


   

Avandia

Avandia

C22H23N3O7S (473.1257)


D007004 - Hypoglycemic Agents

   
   

1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-(6-methyl-1,3-benzothiazol-2-yl)-3-piperidinecarboxamide

1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-(6-methyl-1,3-benzothiazol-2-yl)-3-piperidinecarboxamide

C20H19N5O3S3 (473.065)


   

(6-Bromo-2-pyridin-4-yl-4-quinolinyl)-[4-(2-pyridinyl)-1-piperazinyl]methanone

(6-Bromo-2-pyridin-4-yl-4-quinolinyl)-[4-(2-pyridinyl)-1-piperazinyl]methanone

C24H20BrN5O (473.0851)


   

4-({[3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl]methylene}amino)-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-({[3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl]methylene}amino)-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

C22H15N7O2S2 (473.0729)


   

N-(2,3-dihydro-1,4-benzodioxin-6-ylcarbamoyl)-2-[[5-(2-methoxyanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide

N-(2,3-dihydro-1,4-benzodioxin-6-ylcarbamoyl)-2-[[5-(2-methoxyanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide

C20H19N5O5S2 (473.0828)


   

N-[3-[2-(4-chloroanilino)-4-thiazolyl]phenyl]-3-(trifluoromethyl)benzamide

N-[3-[2-(4-chloroanilino)-4-thiazolyl]phenyl]-3-(trifluoromethyl)benzamide

C23H15ClF3N3OS (473.0576)


   

N-(2,3-dimethylphenyl)-2-[[6-(1,3-dioxo-2-isoindolyl)-1,3-benzothiazol-2-yl]thio]acetamide

N-(2,3-dimethylphenyl)-2-[[6-(1,3-dioxo-2-isoindolyl)-1,3-benzothiazol-2-yl]thio]acetamide

C25H19N3O3S2 (473.0868)


   

1-(4-bromophenyl)-2-[3-[(4-chloroanilino)methyl]-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-4-ium-1-yl]ethanone

1-(4-bromophenyl)-2-[3-[(4-chloroanilino)methyl]-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-4-ium-1-yl]ethanone

C22H23BrClN4O+ (473.0744)


   

4-bromo-N-[3-(dimethylamino)propyl]-N-[4-(4-methoxyphenyl)-2-thiazolyl]benzamide

4-bromo-N-[3-(dimethylamino)propyl]-N-[4-(4-methoxyphenyl)-2-thiazolyl]benzamide

C22H24BrN3O2S (473.0773)


   

4-[(5S)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide

4-[(5S)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide

C20H16Cl2F3N3O3 (473.0521)


   

4-[(5R)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide

4-[(5R)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide

C20H16Cl2F3N3O3 (473.0521)


   

CMP-2-Trimethylaminoethylphosphonate

CMP-2-Trimethylaminoethylphosphonate

C14H27N4O10P2+ (473.1202)


   

S-(2,4-dinitrophenyl)glutathione

S-(2,4-Dinitrophenyl)-Glutathione

C16H19N5O10S (473.0853)


   

6-FAM SE

6-Carboxyfluorescein N-succinimidyl ester

C25H15NO9 (473.0747)


   

Sporidesmin a

Sporidesmin a

C18H20ClN3O6S2 (473.0482)


An organic heteropentacyclic compound that has formula C18H20ClN3O6S2, produced by the saprophyte fungus Pithomyces chartarum. It is a mycotoxin responsible for the hepatogenous photosensitisation disease facial eczema in ruminants.

   

MRTF/SRF-IN-1

MRTF/SRF-IN-1

C24H19ClF3N3O2 (473.1118)


MRTF/SRF-IN-1 (example 41) is an inhibitor of both myocardin-related transcription factor and serum response factor (MRTF/SRF). MRTF/SRF-IN-1 can be used for research for preventing cancer and fibrosis[1].

   

[(2r,3s,4s,5r,6s)-6-{4-[(s)-cyano(hydroxy)methyl]phenoxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

[(2r,3s,4s,5r,6s)-6-{4-[(s)-cyano(hydroxy)methyl]phenoxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C23H23NO10 (473.1322)


   

(2s)-2-[(z)-{1-[(2r)-10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),4,6,10,12-pentaen-4-yl]ethylidene}amino]pentanedioic acid

(2s)-2-[(z)-{1-[(2r)-10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),4,6,10,12-pentaen-4-yl]ethylidene}amino]pentanedioic acid

C23H23NO10 (473.1322)


   

(2r,3s,4r,5r,6s)-6-{4-[(s)-cyano(hydroxy)methyl]phenoxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(2r,3s,4r,5r,6s)-6-{4-[(s)-cyano(hydroxy)methyl]phenoxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C23H23NO10 (473.1322)


   

(2r,3s,4r,5r,6s)-6-{4-[cyano(hydroxy)methyl]phenoxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(2r,3s,4r,5r,6s)-6-{4-[cyano(hydroxy)methyl]phenoxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C23H23NO10 (473.1322)


   

6-{4-[cyano(hydroxy)methyl]phenoxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

6-{4-[cyano(hydroxy)methyl]phenoxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C23H23NO10 (473.1322)


   

(2s)-2-[(e)-{1-[(2r)-10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),4,6,10,12-pentaen-4-yl]ethylidene}amino]pentanedioic acid

(2s)-2-[(e)-{1-[(2r)-10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),4,6,10,12-pentaen-4-yl]ethylidene}amino]pentanedioic acid

C23H23NO10 (473.1322)


   

(2s)-2-{[(2r,3s,4r)-3,4-dihydroxy-6-(methoxycarbonyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl]ethanimidic acid

(2s)-2-{[(2r,3s,4r)-3,4-dihydroxy-6-(methoxycarbonyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl]ethanimidic acid

C18H23N3O12 (473.1282)


   

(2s)-2-({1-[(2r)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),6,10,12-tetraen-4-ylidene]ethyl}amino)pentanedioic acid

(2s)-2-({1-[(2r)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),6,10,12-tetraen-4-ylidene]ethyl}amino)pentanedioic acid

C23H23NO10 (473.1322)


   

2-(4-bromophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

2-(4-bromophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20BrNO3 (473.0626)


   

2-(3-bromophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

2-(3-bromophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20BrNO3 (473.0626)


   

(2r)-2-({1-[(2r)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),6,10,12-tetraen-4-ylidene]ethyl}amino)pentanedioic acid

(2r)-2-({1-[(2r)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),6,10,12-tetraen-4-ylidene]ethyl}amino)pentanedioic acid

C23H23NO10 (473.1322)


   

(2r)-2-{[(2s,3s,4s)-3,4-dihydroxy-6-(methoxycarbonyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl]ethanimidic acid

(2r)-2-{[(2s,3s,4s)-3,4-dihydroxy-6-(methoxycarbonyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl]ethanimidic acid

C18H23N3O12 (473.1282)


   

(6-{4-[cyano(hydroxy)methyl]phenoxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

(6-{4-[cyano(hydroxy)methyl]phenoxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C23H23NO10 (473.1322)


   

2-[(1-{10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),4,6,10,12-pentaen-4-yl}ethylidene)amino]pentanedioic acid

2-[(1-{10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),4,6,10,12-pentaen-4-yl}ethylidene)amino]pentanedioic acid

C23H23NO10 (473.1322)